<DOC>
	<DOCNO>NCT02378441</DOCNO>
	<brief_summary>This study design evaluate safety pharmacokinetic property two treatment , administration CJ-30056 co-administration atorvastatin 20mg metformin SR 750mg , healthy volunteer .</brief_summary>
	<brief_title>Phase 1 Study Compare Safety , Pharmacokinetic Profiles CJ-30056 Lipitor 20mg/Glucophage SR 750mg</brief_title>
	<detailed_description>To evaluate bioequivalence CJ-30056 co-administration atorvastatin 20mg metformin SR 750mg</detailed_description>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>1 . Willing adhere protocol requirement sign inform consent form 2 . Male volunteer age 19 55 year old weight range exceed Â±20 % ideal weight 3 . Subjects history significant chronic disease 4 . Judged good health basis vital sign , ECG , physical exam routine laboratory data 1 . Use barbital inducer inhibitor medication within 28 day dose 2 . Symptom acute illness within 28 day prior drug administration 3 . History clinically significant hepatic , renal , gastrointestinal disease might significantly interfere ADME 4 . History surgery except gastrointestinal disease might significantly change absorption medicine 5 . History clinically significant allergy include drug allergy 6 . History clinically significant allergy atorvastatin metformin 7 . Subjects ever plan intravenous injection contrast medium ( intravenous urography , intravenous cholangiography , compute tomography use contrast medium ) within 28 day prior drug administration 8 . History myopathy 9 . Subjects genetic problem ( galactose intolerance , Lapp lactase deficiency , glucosegalactase malabsorption etc . ) 10 . Clinical laboratory test value outside accept normal range AST ALT &gt; 1.25 time normal range Total bilirubin &gt; 1.5 time normal range eGFR &lt; 90 mL/min 11 . History drug , caffein ( caffein &gt; 400mg/day ) , smoke ( cigarette &gt; 10/day ) alcohol abuse ( alcohol &gt; 30 g/day ) Subjects ever drink within 7 day prior drug administration 12 . Special diet know interfere absorption , distribution , metabolism excretion drug ( especially , consumption grapefruit juice ) within 7 day prior drug administration 13 . Donated blood within 60 day prior dose 14 . Participated previous clinical trial within 60 day prior dose 15 . Use medication , include herbal product , within 10 day dose 16 . Subjects consider unsuitable base medical judgement investigator</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>volunteer</keyword>
</DOC>